Expression of Sme Efflux Pumps and Multilocus Sequence Typing in Clinical Isolates of Stenotrophomonas maltophilia
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Stenotrophomonas maltophilia has emerged as an important opportunistic pathogen, which causes infections that are often difficult to manage because of the inherent resistance of the pathogen to a variety of antimicrobial agents. In this study, we analyzed the expressions of SmeABC and SmeDEF and their correlation with antimicrobial susceptibility. We also evaluated the genetic relatedness and epidemiological links among 33 isolates of S. maltophilia. Methods: In total, 33 S. maltophilia strains were isolated from patients in a tertiary hospital in Daejeon. Minimum inhibitory concentrations (MICs) of 11 antimicrobial agents were determined by using agar dilution method and E-test (BioMérieux, France). Real-time PCR analysis was performed to evaluate the expression of the Sme efflux systems in the S.maltophilia isolates. Additionally, an epidemiological investigation was performed using multilocus sequence typing (MLST) assays. Results: The findings of susceptibility testing showed that the majority of the S. maltophilia isolates were resistant to β-lactams and aminoglycosides. Twenty-one clinical isolates overexpressed SmeABC and showed high resistance to ciprofloxacin. Moreover, a high degree of genetic diversity was observed among the S. maltophilia isolates; 3 sequence types (STs)and 23 allelic profiles were observed. Conclusions: The SmeABC efflux pump was associated with multidrug resistance in clinical isolates of S. maltophilia. In particular, SmeABC efflux pumps appear to perform an important role in ciprofloxacin resistance of S. maltophilia. The MLST scheme for S. maltophilia represents a discriminatory typing method with stable markers and is appropriate for studying population structures.
Abstract
Background: Stenotrophomonas maltophilia has emerged as an important opportunistic pathogen, which causes infections that are often difficult to manage because of the inherent resistance of the pathogen to a variety of antimicrobial agents. In this study, we analyzed the expressions of SmeABC and SmeDEF and their correlation with antimicrobial susceptibility. We also evaluated the genetic relatedness and epidemiological links among 33 isolates of S. maltophilia. Methods: In total, 33 S. maltophilia strains were isolated from patients in a tertiary hospital in Daejeon. Minimum inhibitory concentrations (MICs) of 11 antimicrobial agents were determined by using agar dilution method and E-test (BioMérieux, France). Real-time PCR analysis was performed to evaluate the expression of the Sme efflux systems in the S.maltophilia isolates. Additionally, an epidemiological investigation was performed using multilocus sequence typing (MLST) assays. Results: The findings of susceptibility testing showed that the majority of the S. maltophilia isolates were resistant to β-lactams and aminoglycosides. Twenty-one clinical isolates overexpressed SmeABC and showed high resistance to ciprofloxacin. Moreover, a high degree of genetic diversity was observed among the S. maltophilia isolates; 3 sequence types (STs)and 23 allelic profiles were observed. Conclusions: The SmeABC efflux pump was associated with multidrug resistance in clinical isolates of S. maltophilia. In particular, SmeABC efflux pumps appear to perform an important role in ciprofloxacin resistance of S. maltophilia. The MLST scheme for S. maltophilia represents a discriminatory typing method with stable markers and is appropriate for studying population structures.
참고문헌 (25)
- Hu LF, "Stenotrophomonas maltophilia resistance to trimethoprim", sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron, 2011, pp.37, 230~234
- Liaw SJ, "Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation", Int J Antimicrob Agents, 35, pp.126~130 (2010)
- San Gabriel P, "Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis", Antimicrob Agents Chemother, 48, pp.168~171 (2004)
- Falagas ME, "Therapeutic options for Stenotrophomonas maltophilia infections beyond cotrimoxazole: a systematic review", J Antimicrob Chemother, 62, pp.889~894 (2008)
- Valdezate S, "High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital", J Clin Microbiol, 42, pp.693~699 (2004)
- Li XZ, "SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia", Antimicrob Agents Chemother, 46, pp.333~343 (2002)
- Chang LL, "Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia", Antimicrob Chemother, 53, pp.518~521 (2004)
- Nicodemo AC, "In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods", J Antimicrob Chemother, 53, pp.604~608 (2004)
- Kaiser S, "A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure", J Bacteriol, 191, pp.2934~2943 (2009)
- Foley SL, "Molecular typing methodologies for microbial source tracking and epidemiological investigations of gram-negative bacterial foodborne pathogens", Infect Genet Evol, 9, pp.430~440 (2009)
- Schaumann R, "Molecular typing of clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and random primer PCR fingerprinting", Int J Hyg Environ Health, 211, pp.292~298 (2008)
- National Committee for Clinical Laboratory Standards, "Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically 6th ed. Approved standard NCCLS document M7-A6", CLSI, ~ (2003)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; twentieth informational supplement M100-S20", Clinical and Laboratory Standards Institute, ~ (2010)
- Denton M, "Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia", Clin Microbiol Rev, 11, pp.57~80 (1998)
- Lee K, "Korean nationwide surveillance of antimicrobial resistance of bacteria in 1998", Yonsei Med J, 41, pp.497~506 (2000)
- 이혁민, "2005∼2006년 국내 12개 병원에서 분리된 주요 세균의 항균제 내성률", Annals of Clinical Microbiology, 10(1), pp.59~69 (2007), 대한임상미생물학회
- 장경수, "임상가검물에서 분리한 Stenotrophomonas maltophilia의 유전적 다양성", Journal of Bacteriology and Virology, 37(2), pp.70~79 (2007), 대한미생물학회
- Poole K, "Efflux-mediated multiresistance in gram-negative bacteria", Clin Microbiol Infect, 10, pp.12~26 (2004)
- Quale J, "Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates", Antimicrob Agents Chemother, 50, pp.1633~1641 (2006)
- Zhang L, "Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system", Antimicrob Agents Chemother, 44, pp.287~293 (2000)
- Alonso A, "Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology", J Antimicrob Chemother, 53, pp.432~434 (2004)
- Gould VC, "SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships", J Antimicrob Chemother, 57, pp.1070~1076 (2006)
- 송정훈, "Analysis of Acquired Resistance Genes in Stenotrophomonas maltophilia", Annals of Laboratory Medicine, 30(3), pp.295~300 (2010), 대한진단검사의학회
- Top J, "Emergence of clonal complex 17 Enterococcus faecium in the Netherlands", J Clin Microbiol, 46, pp.214~219 (2008)
- 구선회, "Antimicrobial Resistance and Multilocus Sequence Typing of Vancomycin-Resistant Enterococcus faecium Isolated from the Chungcheong Area", Annals of Clinical Microbiology, 14(2), pp.60~66 (2011), 대한임상미생물학회